Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Expert Practical Recommendations for Hepatocellular Carcinoma103
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns40
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma37
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD33
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype27
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease26
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease25
HBV Biomarkers and Their Role in Guiding Treatment Decisions24
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Towards Precision Medicine in MASLD: Evolution of Disease Subtyping23
MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis20
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy20
Physiomimetic In Vitro Human Models for Viral Infection in the Liver19
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury19
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies17
Wilson Disease: Novel Diagnostic and Therapeutic Approaches15
Mice Engrafted with Human Liver Cells15
Diagnosis and Management of Early Stages of ALD14
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective14
Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates14
13
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure12
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases12
Liver Neurobiology: Regulation of Liver Functions by the Nervous System12
11
Novel Biomarkers of AKI in Cirrhosis11
Role of Complement in Liver Diseases11
Mesenchymal Stem Cell Transplantation in Liver Diseases11
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future11
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure11
11
Combined Hepatocellular-Cholangiocarcinoma: A Clinical and Molecular Review11
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol10
Endoscopic Advances in Hepatology10
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease10
Hepatitis Delta Infection: A Clinical Review10
Management of Portal vein Thrombosis in Cirrhosis10
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy10
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease10
Patient-Centered Treatment of Cirrhosis10
Hepatocellular Carcinoma Chemoprevention with Generic Agents10
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology10
Optimizing Liver Cancer Care Through BCLC Principles10
0.047832012176514